
ADEKIT II – Development of an On-Site Asbestos Detection Kit
Published on 1 September 2024
Publication
The ADEKIT II project, funded by the GreenWin Cluster, aims to develop a rapid asbestos detection kit for construction materials. This innovative system uses specific peptides, a colorimetric detection method, and a portable device, allowing on-site analysis within minutes, enhancing safety and construction site management.
The ADEKIT II project, launched in October 2020, builds on the results of ADEKIT I to develop an industrialized on-site asbestos detection kit. Led by a consortium including D-tek, BuildWise, MBPEL, HTP Europe, SBMI, and CER Groupe, the project aims to deliver a reliable, portable, and fast detection system covering six types of asbestos, ensuring safer construction site management.
Key Objectives of the Project
Improving reliability in real-world conditions
Testing on real construction materials with embedded asbestos fibers.
Adaptation to on-site conditions (temperature, humidity).
Optimization and stabilization of the kit
Development of long-term stable reagent formulations.
Design of an optimized plastic device to reduce production costs and facilitate automation.
Regulatory compliance and environmental impact
Life cycle analysis to optimize the recycling of non-contaminated components.
Regulatory monitoring of European and international asbestos-related standards.
Technical Innovations
Colorimetric detection method using specific peptides (GEPI) fused with beta-lactamase.
Reagent stabilization using cyclodextrin encapsulation to ensure long-term effectiveness.
New device design with a sealed valve system and stepwise reagent application for improved ease of use.
Field usability enhanced through a secure sampling system and a simplified testing protocol.
Testing and Validation
Beta-testing involved 59 professional users from recycling, construction, and laboratory sectors. Among 532 results analyzed, the kit achieved a specificity of 83% and a sensitivity of 74%, confirming its role as a first-line screening tool before laboratory validation.
Future Development and Market Launch
A structured launch plan anticipates the progressive industrialization of the ADEKIT kit, with an expected revenue of €3.5 million over five years. A funding request via Win4 Spin-off is under consideration to structure the commercialization phase.